Validus Capital

Validus Pharmaceuticals is a specialty pharmaceutical company focused on the acquisition, reformulating, and marketing of established legacy pharmaceutical products. The company specializes in maintaining the availability of essential therapies across various therapeutic areas, including psychiatry, neurology, and infectious diseases. Validus manages a portfolio of well-known brands such as Marplan, Rocaltrol, and Mestinon, ensuring these critical medications remain accessible to patients and healthcare providers. By optimizing the commercial lifecycle of mature products, Validus provides value through reliable supply and clinical support for long-standing medical treatments.